Those interested in truly understanding the potential bioterror dangers of the emerging field of synthetic biology should make sure they read and keep updated on the discussion surrounding the Declaration of the Second International Meeting on Synthetic Biology. In this statement, which resulted from a conference attended by some 300 researchers, lawyers, and government policy types, experts in synthetic biology spelled out realistic concerns and suggested ways to go forward.
Also worth tracking is the controversy in the synthetic biology community over a newspaper article in The Guardian that led off with the teaser: “DNA sequences from some of the most deadly pathogens known to man can be bought over the Internet, the Guardian has discovered.” A well-argued critique by Rob Carlson can be found at his website.
On Wednesday, Technologyreview.com will run a Q&A with Drew Endy, a biological engineer at MIT and leading proponent of synthetic biology, asking him about these debates and how to safely proceed with synthetic biology research.
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.